SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

SVB Leerink Maintains Underperform on Clovis Oncology, Lowers Price Target to $4

SVB Leerink maintains Clovis Oncology (NASDAQ:CLVS) with a Underperform and lowers the price target from $5 to $4.

Benzinga · 05/20/2020 10:45

SVB Leerink maintains Clovis Oncology (NASDAQ:CLVS) with a Underperform and lowers the price target from $5 to $4.